The Journal of Immunology, Vol 145, Issue 10 3398-3405, Copyright © 1990 by American Association of Immunologists

ARTICLES

Developmental expression of plasminogen activator inhibitor type 1 by human alveolar macrophages. Possible role in lung injury

HA Chapman, XL Yang, LZ Sailor and DJ Sugarbaker
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.

Urokinase activity is regulated by the specific endogenous plasminogen activator inhibitors type 1 (PAI-1) and type 2 (PAI-2). One of these inhibitors, PAI-1, has been directly implicated in connective tissue metabolism by virtue of its ability to bind extracellular matrix proteins. Because the normal lung is relatively rich in urokinase and abnormalities in urokinase activity have been associated with fibrotic lung diseases, we have explored the possibility of local production of PAI-1 and PAI-2 in human lung. Reverse transcription and subsequent amplification by the polymerase chain reaction of total lung RNA revealed PAI-1 mRNA in each of three normal samples and in two specimens from patients with the adult respiratory distress syndrome (ARDS). In situ hybridizations of lung biopsy specimens from a patient with ARDS with cRNA probes to PAI-1 and PAI-2 indicated that alveolar macrophages express PAI-1 mRNA during the acute injury phase. Subsequent reverse transcription and PCR amplification of normal human monocyte and alveolar macrophage mRNA revealed that neither cell type expressed mRNA for urokinase inhibitors. However, after 24 h stimulation with endotoxin in vitro, monocytes were strongly positive for PAI-2 but negative for PAI-1 mRNA whereas, under the same conditions, alveolar macrophages exhibited mRNA for both PAI-1 and PAI- 2. Metabolic labeling of endotoxin-stimulated alveolar macrophages with 35S-methionine followed by immunoprecipitation with PAI-1 and PAI-2 antibodies revealed that macrophages synthesized both PAI-1 and PAI-2. As judged by immunoprecipitation and functional studies, PAI-2 was found to be the major intracellular PA inhibitor whereas PAI-1 was found to predominate outside the cell. Thus, mononuclear phagocytes exhibit a developmental potential for PAI-1 expression. The release of PAI-1 by stimulated macrophages, as observed in the setting of ARDS, may be one mechanism by which these cells promote connective tissue accumulation.

This article has been cited by other articles:

				R. A. Oeckler and R. D. Hubmayr Ventilator-associated lung injury: a search for better therapeutic targets Eur. Respir. J., December 1, 2007; 30(6): 1216 - 1226. [Abstract] [Full Text] [PDF]

				H Kliem, H Welter, W D Kraetzl, M Steffl, H H D Meyer, D Schams, and B Berisha Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum Reproduction, September 1, 2007; 134(3): 535 - 547. [Abstract] [Full Text] [PDF]

				M. Wygrecka, P. Markart, C. Ruppert, K. Petri, K. T. Preissner, W. Seeger, and A. Guenther Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs Eur. Respir. J., June 1, 2007; 29(6): 1105 - 1114. [Abstract] [Full Text] [PDF]

				K. Ganguly, J.-C. Murciano, R. Westrick, J. Leferovich, D. B. Cines, and V. R. Muzykantov The Glycocalyx Protects Erythrocyte-Bound Tissue-Type Plasminogen Activator from Enzymatic Inhibition J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 158 - 164. [Abstract] [Full Text] [PDF]

				K. Cederqvist, V. Siren, J. Petaja, A. Vaheri, C. Haglund, and S. Andersson High Concentrations of Plasminogen Activator Inhibitor-1 in Lungs of Preterm Infants With Respiratory Distress Syndrome Pediatrics, April 1, 2006; 117(4): 1226 - 1234. [Abstract] [Full Text] [PDF]

				P. G. Arndt, S. K. Young, and G. S. Worthen Regulation of Lipopolysaccharide-Induced Lung Inflammation by Plasminogen Activator Inhibitor-1 through a JNK-Mediated Pathway J. Immunol., September 15, 2005; 175(6): 4049 - 4059. [Abstract] [Full Text] [PDF]

				J. D. Savov, D. M. Brass, K. G. Berman, E. McElvania, and D. A. Schwartz Fibrinolysis in LPS-induced chronic airway disease Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L940 - L948. [Abstract] [Full Text] [PDF]

				P. Prabhakaran, L. B. Ware, K. E. White, M. T. Cross, M. A. Matthay, and M. A. Olman Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L20 - L28. [Abstract] [Full Text] [PDF]

				R. T. Schermuly, A. Gunther, M. Ermert, L. Ermert, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, and D. Walmrath Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L792 - L800. [Abstract] [Full Text] [PDF]

				M. R. Horton, M. A. Olman, C. Bao, K. E. White, A. M. K. Choi, B.-Y. Chin, P. W. Noble, and C. J. Lowenstein Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages Am J Physiol Lung Cell Mol Physiol, October 1, 2000; 279(4): L707 - L715. [Abstract] [Full Text] [PDF]

				A. Agah, M. C. Montalto, C. L. Kiesecker, M. Morrissey, M. Grover, K. L. Whoolery, R. P. Rother, and G. L. Stahl Isolation, Characterization, and Cloning of Porcine Complement Component C7 J. Immunol., July 15, 2000; 165(2): 1059 - 1065. [Abstract] [Full Text] [PDF]

				A. GÜNTHER, P. MOSAVI, S. HEINEMANN, C. RUPPERT, H. MUTH, P. MARKART, F. GRIMMINGER, D. WALMRATH, B. TEMMESFELD-WOLLBRÜCK, and W. SEEGER Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia . Comparison with the Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 454 - 462. [Abstract] [Full Text]

				C. G. LARDOT, F. A. HUAUX, F. R. BROECKAERT, P. J. DECLERCK, M. DELOS, B. FUBINI, and D. F. LISON Role of Urokinase in the Fibrogenic Response of the Lung to Mineral Particles Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 617 - 628. [Abstract] [Full Text]